Şükriye Yeşilot

448 total citations
34 papers, 343 citations indexed

About

Şükriye Yeşilot is a scholar working on Pathology and Forensic Medicine, Materials Chemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Şükriye Yeşilot has authored 34 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 8 papers in Materials Chemistry and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Şükriye Yeşilot's work include Nanoparticles: synthesis and applications (8 papers), Chemotherapy-induced organ toxicity mitigation (6 papers) and Diet, Metabolism, and Disease (5 papers). Şükriye Yeşilot is often cited by papers focused on Nanoparticles: synthesis and applications (8 papers), Chemotherapy-induced organ toxicity mitigation (6 papers) and Diet, Metabolism, and Disease (5 papers). Şükriye Yeşilot collaborates with scholars based in Türkiye and Kazakhstan. Şükriye Yeşilot's co-authors include Çiğdem Aydın, Dilek Bayram, Mehtap Savran, Halil Aşçı, Mehmet Kaya Özer, Meral Öncü, Mustafa Saygın, Özlem Özmen, Ekrem Çiçek and Şenay Topsakal and has published in prestigious journals such as SHILAP Revista de lepidopterología, Food and Chemical Toxicology and Cytokine.

In The Last Decade

Şükriye Yeşilot

30 papers receiving 337 citations

Peers

Şükriye Yeşilot
Comparison fields: 5 of 88
  • Materials Chemistry 104
  • Pharmacology 61
  • Pathology and Forensic Medicine 55
  • Biomedical Engineering 47
  • Plant Science 41
Replace Ehsan Zamani with:
Ehsan Zamani Iran
Zakaria El-Khayat Egypt
Laila Naif Al‐Harbi Saudi Arabia
Fiaz Ahmad Pakistan
Laila M. Faddah Saudi Arabia
Muhammad Asim Shabbir Pakistan
Fawziah A. Al‐Salmi Saudi Arabia
Nobuo Hoshino Japan
Hanaa M. Ali Egypt
Nouf Omar Alafaleq Saudi Arabia
Ehsan Zamani Iran View profile →
Citations per field, relative to Şükriye Yeşilot
Şükriye Yeşilot · 1×
Citations per year, relative to Şükriye Yeşilot
Şükriye Yeşilot · 1×

Countries citing papers authored by Şükriye Yeşilot

Since Specialization
Citations

This map shows the geographic impact of Şükriye Yeşilot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Şükriye Yeşilot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Şükriye Yeşilot more than expected).

Fields of papers citing papers by Şükriye Yeşilot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Şükriye Yeşilot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Şükriye Yeşilot. The network helps show where Şükriye Yeşilot may publish in the future.

Co-authorship network of co-authors of Şükriye Yeşilot

This figure shows the co-authorship network connecting the top 25 collaborators of Şükriye Yeşilot. A scholar is included among the top collaborators of Şükriye Yeşilot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Şükriye Yeşilot. Şükriye Yeşilot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 0
3 3
4 12
5 1
6 29
7 6
8 1
9 1
10 7
11 11
12
CYTOTOXIC EFFECT OF GREEN SYNTHESIZED SILVER NANOPARTICLES WITH SALVIA OFFICINALIS ON MCF-7 HUMAN BREAST CANCER CELLS
2
13 15
14 68
15 11
16 14
17
EVALUATION OF POTENTIALLY INAPPROPRIATE DRUG USE AND MEDICAL NON-ADHERENCE IN A COMMUNITY-DWELLING ELDERLY POPULATION: A CROSS-SECTIONAL STUDY
5
18
Effects of Misoprostol on Methotrexate-Induced Hepatic and Renal Damages
6
19 18
20 31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026